Covered Metal Ureteral Stents in the Treatment of Benign Short Ureteral Stricture
Evaluation of Curative Effect of Covered Metal Ureteral Stents in the Endoscopic Treatment of Benign Short Ureteral Stricture: a Prospective Controlled Study
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
BSUS patients were prospectively enrolled in this study, and non-randomly treated with "balloon dilation +CMUS" and "balloon dilation + tandem DJ stent". Perioperative data of the patients were recorded to compare their efficacy and complications, and the ureteral stent symptom questionnaire was used to compare their impact on patients' quality of life. CMUS and tandem DJ stents were removed after ≥3 months of indwelling. After the removal of stents, the patients' serum creatinine and renal pelvis width were followed up to compare their curative effect on BSUS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2022
CompletedFirst Posted
Study publicly available on registry
June 24, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJune 24, 2022
June 1, 2022
2 years
June 13, 2022
June 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Postoperative Serum Creatinine (SCr)
It represents for the renal function change after ureteral stent insertion.
Postoperative 3-month
Serum Creatinine (SCr) after stent removal
It represents for the curative effect of balloon dilatation and ureteral stent.
Three-month after stent removal
Postoperative Renal pelvic width (RPW)
It represents for the change of hydronephrosis after ureteral stent insertion.
Postoperative 3-month
Renal pelvic width (RPW) after stent removal
It represents for the curative effect of balloon dilatation and ureteral stent.
Three-month after stent removal
Ureteral stent symptom questionnaire (USSQ)
USSQ represents for the quality of life of patients with ureteral stents.
Postoperative 3-month
Secondary Outcomes (1)
Complications
Postoperative 3-month
Study Arms (2)
CMUS group
EXPERIMENTALBalloon dilatation and CMUS insertion were performed in this group.
Tandem DJ stent group
ACTIVE COMPARATORBalloon dilatation and Tandem DJ stent insertion were performed in this group.
Interventions
The CMUS is a fully covered, self-expanding, large caliber metal stent. The stent is made of super-elastic nickel-titanium alloy, which maintain lumen patency via providing long-term direct wall support.
Tandem DJ stents represents for two stents side-by-side, which improves the urine flow by better withstanding the compressive tumoral forces and allowing urine to flow between the stents.
Eligibility Criteria
You may qualify if:
- BSUS patients from January 2023 to January 2024 in Peking University People's Hospital, no gender limitation, aged from 18 to 80, Benign ureteral stricture with definite reason (ureteropelvic junction obstruction, ischemic ureter stenosis caused by surgical separation, ureter partial excision anastomosis stricture after operation, ureteral stricture caused by ureteral endoscope surgery, ureteral stenosis caused by impacted ureteral calculi, ureteral anastomotic stricture after urinary flow diversion, ureteral anastomotic stricture after kidney transplantation, retroperitoneal fibrosis, ureteral stricture caused by trauma, idiopathic ureteral stricture), patients can tolerate anesthesia and surgery and obtain informed consent.
You may not qualify if:
- Patients with hypertonic neurogenic bladder, severe bladder outlet obstruction or bladder capacity less than 50ml, combined with sepsis, incomplete clinical data, failed stent implantation, insufficient indwelling time (\< 3 months), postoperative loss of follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 13, 2022
First Posted
June 24, 2022
Study Start
January 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
June 24, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share